Teva Pharmaceutical Industries (TEVA) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Teva Pharmaceutical Industries Revenue Highlights

Latest Revenue (Y)

$17.26B

Latest Revenue (Q)

$4.48B

Main Segment (Y)

Product

Main Geography (Y)

United States Segment

Teva Pharmaceutical Industries Revenue by Period

Teva Pharmaceutical Industries Revenue by Year

Date	Revenue	Change
2025-12-31	$17.26B	4.32%
2024-12-31	$16.54B	4.41%
2023-12-31	$15.85B	6.16%
2022-12-31	$14.93B	-6.00%
2021-12-31	$15.88B	-4.69%
2020-12-31	$16.66B	-1.35%
2019-12-31	$16.89B	-10.43%
2018-12-31	$18.85B	-15.77%
2017-12-31	$22.39B	2.20%
2016-12-31	$21.90B	11.45%
2015-12-31	$19.65B	-3.06%
2014-12-31	$20.27B	-0.21%
2013-12-31	$20.31B	-0.01%
2012-12-31	$20.32B	10.95%
2011-12-31	$18.31B	13.59%
2010-12-31	$16.12B	15.99%
2009-12-31	$13.90B	25.39%
2008-12-31	$11.09B	17.83%
2007-12-31	$9.41B	11.89%
2006-12-31	$8.41B	60.14%
2005-12-31	$5.25B	9.41%
2004-12-31	$4.80B	46.47%
2003-12-31	$3.28B	30.09%
2002-12-31	$2.52B	21.24%
2001-12-31	$2.08B	18.72%
2000-12-31	$1.75B	36.45%
1999-12-31	$1.28B	14.92%
1998-12-31	$1.12B	-0.09%
1997-12-31	$1.12B	17.10%
1996-12-31	$953.80M	42.85%
1995-12-31	$667.70M	13.61%
1994-12-31	$587.70M	17.07%
1993-12-31	$502.00M	-

Teva Pharmaceutical Industries generated $17.26B in revenue during NA 2025, up 4.32% compared to the previous quarter, and up 103.60% compared to the same period a year ago.

Teva Pharmaceutical Industries Revenue by Quarter

Date	Revenue	Change
2025-09-30	$4.48B	7.28%
2025-06-30	$4.18B	7.32%
2025-03-31	$3.89B	-7.99%
2024-12-31	$4.23B	-2.38%
2024-09-30	$4.33B	4.08%
2024-06-30	$4.16B	8.61%
2024-03-31	$3.83B	-14.02%
2023-12-31	$4.46B	15.77%
2023-09-30	$3.85B	-0.72%
2023-06-30	$3.88B	5.90%
2023-03-31	$3.66B	-5.72%
2022-12-31	$3.88B	8.04%
2022-09-30	$3.60B	-5.02%
2022-06-30	$3.79B	3.39%
2022-03-31	$3.66B	-10.71%
2021-12-31	$4.10B	5.51%
2021-09-30	$3.89B	-0.61%
2021-06-30	$3.91B	-1.81%
2021-03-31	$3.98B	-10.56%
2020-12-31	$4.45B	11.92%
2020-09-30	$3.98B	2.79%
2020-06-30	$3.87B	-11.18%
2020-03-31	$4.36B	-2.48%
2019-12-31	$4.47B	4.78%
2019-09-30	$4.26B	-1.68%
2019-06-30	$4.34B	0.98%
2019-03-31	$4.29B	-5.79%
2018-12-31	$4.56B	0.66%
2018-09-30	$4.53B	-3.66%
2018-06-30	$4.70B	-7.19%
2018-03-31	$5.07B	-7.22%
2017-12-31	$5.46B	-2.69%
2017-09-30	$5.61B	-1.34%
2017-06-30	$5.69B	0.99%
2017-03-31	$5.63B	-13.28%
2016-12-31	$6.49B	16.70%
2016-09-30	$5.56B	10.42%
2016-06-30	$5.04B	4.74%
2016-03-31	$4.81B	-1.45%
2015-12-31	$4.88B	1.20%
2015-09-30	$4.82B	-2.88%
2015-06-30	$4.97B	-0.32%
2015-03-31	$4.98B	-3.60%
2014-12-31	$5.17B	2.17%
2014-09-30	$5.06B	0.26%
2014-06-30	$5.04B	0.88%
2014-03-31	$5.00B	-7.90%
2013-12-31	$5.43B	7.33%
2013-09-30	$5.06B	2.74%
2013-06-30	$4.92B	0.47%
2013-03-31	$4.90B	-6.63%
2012-12-31	$5.25B	5.57%
2012-09-30	$4.97B	-0.44%
2012-06-30	$4.99B	-2.12%
2012-03-31	$5.10B	-10.11%
2011-12-31	$5.68B	30.66%
2011-09-30	$4.34B	3.13%
2011-06-30	$4.21B	3.24%
2011-03-31	$4.08B	-7.65%
2010-12-31	$4.42B	3.95%
2010-09-30	$4.25B	11.84%
2010-06-30	$3.80B	4.02%
2010-03-31	$3.65B	-3.92%
2009-12-31	$3.80B	7.10%
2009-09-30	$3.55B	4.41%
2009-06-30	$3.40B	8.04%
2009-03-31	$3.15B	10.50%
2008-12-31	$2.85B	0.21%
2008-09-30	$2.84B	0.67%
2008-06-30	$2.82B	9.76%
2008-03-31	$2.57B	-

Teva Pharmaceutical Industries generated $4.48B in revenue during Q3 2025, up 7.28% compared to the previous quarter, and up 107.64% compared to the same period a year ago.

Teva Pharmaceutical Industries Revenue Breakdown

Teva Pharmaceutical Industries Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Distribution Service	$1.55B	$1.58B	-	-	-
License	$678.00M	$173.00M	-	-	-
Product and Service, Other	$423.00M	$365.00M	-	-	-
Product	$14.61B	$14.43B	-	-	-
Other Activities	-	-	$926.00M	$1.04B	$1.15B
International Markets	-	-	$1.96B	$1.90B	$2.03B

Teva Pharmaceutical Industries's latest annual revenue breakdown by segment (product or service), as of Dec 25: Product (84.63%), Distribution Service (8.99%), License (3.93%), and Product and Service, Other (2.45%).

Quarterly Revenue by Product

Product/Service	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
Product	$3.67B	$3.91B	$3.64B	$3.40B	$7.00B	$3.79B	$3.64B	-	-	-	-	-	-	-	-	-	-	-	-	-
License	$550.00M	$46.00M	$46.00M	$36.00M	$92.00M	$45.00M	$36.00M	-	-	-	-	-	-	-	-	-	-	-	-	-
Distribution Service	$384.00M	$406.00M	$377.00M	$384.00M	$804.00M	$390.00M	$382.00M	-	-	-	-	-	-	-	-	-	-	-	-	-
Product and Service, Other	$109.00M	$121.00M	$117.00M	$76.00M	$157.00M	$102.00M	$106.00M	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Activities	-	-	-	-	-	-	-	$462.00M	$245.00M	$219.00M	$272.00M	$241.00M	$257.00M	$275.00M	$302.00M	$262.00M	$298.00M	$289.00M	$345.00M	$316.00M
International Markets	-	-	-	-	-	-	-	$987.00M	$479.00M	$492.00M	$481.00M	$475.00M	$454.00M	$492.00M	$527.00M	$530.00M	$485.00M	$490.00M	$572.00M	$529.00M

Teva Pharmaceutical Industries's latest quarterly revenue breakdown by segment (product or service), as of Dec 25: Product (77.86%), License (11.68%), Distribution Service (8.15%), and Product and Service, Other (2.31%).

Teva Pharmaceutical Industries Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Europe Segment	$5.04B	$5.10B	-	-	-
International Markets	$2.16B	$2.46B	-	-	-
United States Segment	$9.19B	-	-	-	-
UNITED STATES	-	$8.03B	-	-	-
Europe	-	$5.10B	$4.84B	$4.46B	$4.81B
North America Segment	-	$8.03B	-	-	-
North America	-	-	$8.12B	$5.83B	$6.39B

Teva Pharmaceutical Industries's latest annual revenue breakdown by geography, as of Dec 25: United States Segment (56.05%), Europe Segment (30.75%), and International Markets (13.19%).

Quarterly Revenue by Country

Country	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20
Europe Segment	$1.31B	$1.24B	$1.30B	$1.19B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
United States Segment	$4.55B	$2.48B	$2.15B	$1.91B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
International Markets	$528.00M	$557.00M	$495.00M	$582.00M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
UNITED STATES	-	-	-	$1.91B	$3.70B	$2.23B	$2.11B	-	-	-	-	-	-	-	-	-	-	-	-	-
North America Segment	-	-	-	$1.91B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Europe	-	-	-	$1.20B	$2.63B	$1.26B	$1.21B	$2.51B	$1.15B	$1.18B	$1.16B	$1.03B	$1.13B	$1.13B	$1.25B	$1.20B	$1.19B	$1.18B	$1.25B	$7.00M
North America	-	-	-	-	-	-	-	$5.23B	$1.58B	$1.32B	$1.53B	$1.39B	$1.54B	$1.38B	$1.62B	$1.49B	$1.62B	$1.67B	$1.96B	$1.66B

Teva Pharmaceutical Industries's latest quarterly revenue breakdown by geography, as of Dec 25: United States Segment (71.20%), Europe Segment (20.54%), and International Markets (8.26%).

Teva Pharmaceutical Industries Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
PHG	Koninklijke Philips	$18.17B	$4.14B
TEVA	Teva Pharmaceutical Industries	$17.26B	$4.48B
LH	Labcorp	$13.95B	$3.56B
BIIB	Biogen	$9.81B	$2.53B
STE	STERIS	$5.46B	$1.50B
DXCM	DexCom	$4.66B	$1.21B
BNTX	BioNTech SE	$3.82B	$187.60M
WAT	Waters	$3.17B	$799.89M
NBIX	Neurocrine Biosciences	$2.86B	$794.90M
PODD	Insulet	$2.71B	$706.30M
NTRA	Natera	$2.31B	$592.18M

TEVA Revenue FAQ

What is Teva Pharmaceutical Industries’s yearly revenue?

Teva Pharmaceutical Industries's yearly revenue for 2025 was $17.26B, representing an increase of 4.32% compared to 2024. The company's yearly revenue for 2024 was $16.54B, representing an increase of 4.41% compared to 2023. TEVA's yearly revenue for 2023 was $15.84B, representing an increase of 6.16% compared to 2022.

What is Teva Pharmaceutical Industries’s quarterly revenue?

Teva Pharmaceutical Industries's quarterly revenue for Q3 2025 was $4.48B, a 7.28% increase from the previous quarter (Q2 2025), and a 3.42% increase year-over-year (Q3 2024). The company's quarterly revenue for Q2 2025 was $4.18B, a 7.32% increase from the previous quarter (Q1 2025), and a 0.34% increase year-over-year (Q2 2024). TEVA's quarterly revenue for Q1 2025 was $3.89B, a -7.99% decrease from the previous quarter (Q4 2024), and a 1.54% increase year-over-year (Q1 2024).

What is Teva Pharmaceutical Industries’s revenue growth rate?

Teva Pharmaceutical Industries's revenue growth rate for the last 3 years (2023-2025) was 8.92%, and for the last 5 years (2021-2025) was 8.69%.

What are Teva Pharmaceutical Industries’s revenue streams?

Teva Pharmaceutical Industries's revenue streams in c 25 are Distribution Service, License, Product and Service, Other, and Product. Distribution Service generated $1.55B in revenue, accounting 8.99% of the company's total revenue, down -1.59% year-over-year. License generated $678M in revenue, accounting 3.93% of the company's total revenue, up 291.91% year-over-year. Product and Service, Other generated $423M in revenue, accounting 2.45% of the company's total revenue, up 15.89% year-over-year. Product generated $14.6B in revenue, accounting 84.63% of the company's total revenue, up 1.21% year-over-year.

What is Teva Pharmaceutical Industries’s main source of revenue?

For the fiscal year ending Dec 25, the largest source of revenue of Teva Pharmaceutical Industries was Product. This segment made a revenue of $14.6B, representing 84.63% of the company's total revenue.